Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

GIRK1 triggers multiple cancer-related pathways in the benign mammary epithelial cell line MCF10A.

Schratter G, Scheruebel S, Langthaler S, Ester K, Pelzmann B, Ghaffari-Tabrizi-Wizsy N, Rezania S, Gorischek A, Platzer D, Zorn-Pauly K, Ahammer H, Prokesch A, Stanzer S, Devaney TTJ, Schmidt K, Jahn SW, Prassl R, Bauernhofer T, Schreibmayer W.

Sci Rep. 2019 Dec 17;9(1):19277. doi: 10.1038/s41598-019-55683-w.

2.

Chronic Oxidative Stress Promotes Molecular Changes Associated with Epithelial Mesenchymal Transition, NRF2, and Breast Cancer Stem Cell Phenotype.

Čipak Gašparović A, Milković L, Dandachi N, Stanzer S, Pezdirc I, Vrančić J, Šitić S, Suppan C, Balic M.

Antioxidants (Basel). 2019 Dec 11;8(12). pii: E633. doi: 10.3390/antiox8120633.

3.

MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.

Schwarzenbacher D, Klec C, Pasculli B, Cerk S, Rinner B, Karbiener M, Ivan C, Barbano R, Ling H, Wulf-Goldenberg A, Stanzer S, Rinnerthaler G, Stoeger H, Bauernhofer T, Haybaeck J, Hoefler G, Jahn SW, Parrella P, Calin GA, Pichler M.

Breast Cancer Res. 2019 Feb 1;21(1):20. doi: 10.1186/s13058-019-1104-5.

4.

A Pilot Randomized Trial Assessing the Effect of a Psychoeducational Intervention on Psychoneuroimmunological Parameters Among Patients With Nonmetastatic Breast Cancer.

Stanzer S, Andritsch E, Zloklikovits S, Ladinek V, Farkas C, Augustin T, Obermayer-Pietsch B, Samonigg H, Bauernhofer T.

Psychosom Med. 2019 Feb/Mar;81(2):165-175. doi: 10.1097/PSY.0000000000000656.

PMID:
30489436
5.

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.

Brcic L, Stanzer S, Krenbek D, Gruber-Moesenbacher U, Absenger G, Quehenberger F, Valipour A, Lindenmann J, Stoeger H, Al Effah M, Fediuk M, Balic M, Popper HH.

Virchows Arch. 2018 Apr;472(4):589-598. doi: 10.1007/s00428-018-2326-0. Epub 2018 Mar 8.

6.

Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition.

Tiran V, Lindenmann J, Brcic L, Heitzer E, Stanzer S, Tabrizi-Wizsy NG, Stacher E, Stoeger H, Popper HH, Balic M, Dandachi N.

Sci Rep. 2017 Aug 30;7(1):10040. doi: 10.1038/s41598-017-09929-0.

7.

Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.

Tiran V, Stanzer S, Heitzer E, Meilinger M, Rossmann C, Lax S, Tsybrovskyy O, Dandachi N, Balic M.

PLoS One. 2017 Apr 19;12(4):e0175223. doi: 10.1371/journal.pone.0175223. eCollection 2017.

8.

Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.

Urbas R, Mayr C, Klieser E, Fuereder J, Bach D, Stättner S, Primavesi F, Jaeger T, Stanzer S, Ress AL, Löffelberger M, Wagner A, Berr F, Ritter M, Pichler M, Neureiter D, Kiesslich T.

Int J Mol Sci. 2016 Dec 7;17(12). pii: E2053.

9.

Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells.

Pehserl AM, Ress AL, Stanzer S, Resel M, Karbiener M, Stadelmeyer E, Stiegelbauer V, Gerger A, Mayr C, Scheideler M, Hutterer GC, Bauernhofer T, Kiesslich T, Pichler M.

Int J Mol Sci. 2016 Dec 1;17(12). pii: E2011.

10.

Genetic and epigenetic analysis of putative breast cancer stem cell models.

Balic M, Schwarzenbacher D, Stanzer S, Heitzer E, Auer M, Geigl JB, Cote RJ, Datar RH, Dandachi N.

BMC Cancer. 2013 Jul 24;13:358. doi: 10.1186/1471-2407-13-358.

11.

Effect of oxidative stress and endotoxin on human serum albumin in brain-dead organ donors.

Leber B, Stadlbauer V, Stiegler P, Stanzer S, Mayrhauser U, Koestenbauer S, Leopold B, Sereinigg M, Puntschart A, Stojakovic T, Tscheliessnigg KH, Oettl K.

Transl Res. 2012 Jun;159(6):487-96. doi: 10.1016/j.trsl.2011.12.005. Epub 2012 Jan 9.

PMID:
22633100
12.

Rapid and reliable detection of LINE-1 hypomethylation using high-resolution melting analysis.

Stanzer S, Balic M, Strutz J, Heitzer E, Obermair F, Hauser-Kronberger C, Samonigg H, Dandachi N.

Clin Biochem. 2010 Dec;43(18):1443-8. doi: 10.1016/j.clinbiochem.2010.09.013. Epub 2010 Sep 27.

PMID:
20883681
13.

Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells.

Balic M, Rapp N, Stanzer S, Lin H, Strutz J, Szkandera J, Daidone MG, Samonigg H, Cote RJ, Dandachi N.

Appl Immunohistochem Mol Morphol. 2011 Jan;19(1):33-40. doi: 10.1097/PAI.0b013e3181ebf4e8.

PMID:
20861793
14.

The role of activation-induced cell death in the higher onset of spontaneous apoptosis of NK cell subsets in patients with metastatic epithelial cancer.

Stanzer S, Janesch B, Resel M, Augustin T, Samonigg H, Bauernhofer T.

Cell Immunol. 2010;261(2):99-104. doi: 10.1016/j.cellimm.2009.11.006. Epub 2009 Nov 26.

PMID:
20035932
15.

Optimization of diagnostic ELISA-based tests for the detection of auto-antibodies against tumor antigens in human serum.

Stefatić D, Riederer M, Balić M, Dandachi N, Stanzer S, Janesch B, Resel M, Ler D, Samonigg H, Bauernhofer T.

Bosn J Basic Med Sci. 2008 Aug;8(3):245-50.

16.

Resistance to apoptosis and expansion of regulatory T cells in relation to the detection of circulating tumor cells in patients with metastatic epithelial cancer.

Stanzer S, Dandachi N, Balic M, Resel M, Samonigg H, Bauernhofer T.

J Clin Immunol. 2008 Mar;28(2):107-14. Epub 2007 Oct 16.

PMID:
17939021
17.

Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients.

Dandachi N, Balic M, Stanzer S, Halm M, Resel M, Hinterleitner TA, Samonigg H, Bauernhofer T.

J Mol Diagn. 2005 Nov;7(5):631-7.

Supplemental Content

Loading ...
Support Center